IJMABHR International Journal of Medical and All Body Health ResearchIJMABHR 2582-8940 Anfo Publication House 352 10.54660/IJMBHR.2025.6.3.13-16 The Treatment Results Stillbirth in the Second and Third Trimesters by Misoprostol NgaMai Thi Buon Ma Thuot Medical University, Buon Ma Thuot, Dak Lak 630000, Vietnam 03072025 6 3 13 16 08052025 07062025 CC BY-NC-SA 4.0

The study carried out on 57 women with stillbirth in the second and third trimesters of pregnancy and was treatment by misoprostol at obstetrics and gynecology department in Vung Tay Nguyen General Hospital from 1/2024-12/2024. The success rate with medical abortion is 84,2%, of which the complete expulsion rate is 12,5%, incomplete is 87,5 %. The average total dose is 362,3 ± 290,3 mcg, which of 577,4 ± 227,6 mcg in second trimester and in third trimester is 105,8 ± 26,8 mcg (p

 StillbirrthTreatmentSecond TrimesterThird TrimesterMisoprostol References Gomez R, Wing D. Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy - a systematic review. Contraception. 2009;79(4):259 -71. doi:10.1016/j.contraception.2008.10.012. Sultana Z, Rahman MM, Begum M, Akhter S, Nahar K. Induction by misoprostol in case of intrauterine fetal death: a cross-sectional study. Mymensingh Med J. 2020;29(3):616-22. Amin KV, Chauhan AR, Goel A. Current practices of cervical ripening and induction of labour in intrauterine foetal demise: an observational study. J Obstet Gynaecol India. 2019;69(1):37-42. doi:10.1007/s13224-018-1113-9. Das SR, Akhter S, Begum M, Nahar K. Safety and efficacy of different doses of misoprostol in termination International Journal of Medical and All Body Health Research www.allmedicaljournal.com of intrauterine fetal death (IUFD) cases. Bangladesh J Obstet Gynaecol. 2016;28(1):15-20. Gomez R, Wing D, Fiala C. Misoprostol for intrauterine fetal death. Int J Gynaecol Obstet. 2007;99 Suppl 2:S190-3. doi:10.1016/j.ijgo.2007.09.004. Palod S, Nayak T. Use of misoprostol for termination of second and third trimester pregnancy with intrauterine foetal death. Int J Reprod Contracept Obstet Gynecol. 2016;5(4):1216-21. doi:10.18203/2320 -1770.ijrcog20160931. Cetin C, Yucel B, Ozdemir O, Cetin M. Comparison of two misoprostol regimens for mid-trimester pregnancy terminations after FIGO's misoprostol dosage recommendation in 2012. J Matern Fetal Neonatal Med. 2016;29(8):1314-7. doi:10.3109/14767058.2015.1046825. El-Gharib MN, Elebyary MT. Low-dose vaginal misoprostol in the management of intrauterine fetal death. J Matern Fetal Neonatal Med. 2011;24(10):1239-42. doi:10.3109/14767058.2010.547963. Bracken H, Dabash R, Tsertsvadze G, Posohova S, Shah M, Hajri S, et al. Buccal misoprostol for treatment of fetal death at 14-28 weeks of pregnancy: a double-blind randomized controlled trial. Contraception. 2014;89(3):187-92. doi:10.1016/j.contraception.2013.11.009. Cleeve A, Fonhus MS, Lavelanet A. A systematic review of the effectiveness, safety, and acceptability of medical management of intrauterine fetal death at 14-28 weeks of gestation. Int J Gynaecol Obstet. 2019;147(3):301-12. doi:10.1002/ijgo.12951. Ministry of Health. Stillbirth. In: National guidelines on reproductive health services. Ministry of Health; 2016. p. 125-7. United Nations Inter-agency Group for Child Mortality Estimation. A neglected tragedy: the global burden of stillbirths. New York: UNICEF; 2020. Vo Thi Thanh Huyen. Evaluation of the effectiveness of misoprostol in the management of first and second trimester intrauterine fetal death [Specialist Thesis Level II]. Hue University of Medicine and Pharmacy; 2024. Pham Thi Linh, Truong My Ngoc, Le Thi My Tien. Evaluation of the outcomes of pregnancy termination with misoprostol at 13 to 22 weeks of gestation at Can Tho City Obstetrics Hospital [Institution-Level Research Project]. Can Tho City Obstetrics Hospital; 2018.